INTRODUCTION {#S1}
============

Murine epidermis is maintained by tissue stem cells that can be defined by their long-term repopulating and self-renewal abilities. These defining features are essential to the identification and characterization of epidermal stem cells **(EpiSCs)** and their progeny.

Keratinocytes spontaneously form cysts with a differentiated keratinizing epidermis, following traumatic or surgical implantation into the human subcutis ([@R19]; [@R53]; [@R41]). Production of such cysts has been used to study conjunctival epithelium ([@R13]; [@R63]), lung alveolar cells ([@R70]) and epidermal keratinocytes ([@R17]; [@R72]). Epidermal keratinocytes produced stratified squamous structures with keratohyalin granules, stratum corneum, basement membrane, and protein expression indicating a fully differentiated epidermis ([@R13]; [@R17]). Thus, subcutaneous injection of keratinocytes into mice results in the phenotype and differentiation pattern of the original epidermis.

CD133^+^ marked human progenitors in kidney ([@R6]), nervous system ([@R62]) and in epithelial tissues including prostate ([@R45]), foreskin ([@R71]; [@R38]; [@R18]) and colorectal adenocarcinoma ([@R9]). CD133 marked murine progenitors in neural cells ([@R10]; [@R11]), liver ([@R46]), kidney ([@R64]) and intestine ([@R54]; [@R73]). We selected CD133 as a possible marker of murine EpiSCs.

Murine embryonic stem cells with high mitochondrial membrane potential **(ΔΨm)** show decreased differentiation and increased teratoma formation ([@R47]). TMRM, a fluorescent derivative of R123, was used to isolate putative EpiSCs based on high ΔΨm, as it provides more accurate quantification than the parent compound ([@R50]).

In both human and murine epidermis, integrin α6^hi^CD71^lo^ keratinocytes showed features of stem cells ([@R25]; [@R32]; [@R57]).

In this study, epidermal allografts were produced by injection of putative EpiSCs into murine subcutis. The frequency of long-term repopulating EpiSCs was determined by limiting dilution analysis ([@R49]; [@R7]; [@R55]). Enrichment for murine EpiSCs was 3.9- fold over unfractionated (UNF) keratinocytes in CD133^+^ keratinocytes and 5.2-fold in CD133^+^ΨΔm^hi^ keratinocytes. CD133^+^ and CD133^+^ΨΔm^hi^ keratinocytes displayed superior long-term repopulating and self-renewal ability, multipotency, and label retention.

RESULTS {#S2}
=======

Generation of murine epidermal repopulating units in an allograft model {#S3}
-----------------------------------------------------------------------

Epidermal structures generated from injection of keratinocytes were termed epidermal repopulating units **(ERUs)** pursuant to hematologic terminology ([@R56]). After injection of GFP^+^ keratinocytes, 100% of 100 ERUs analyzed were GFP^+^, confirming derivation from GFP^+^ keratinocytes injected ([Figure 1a](#F1){ref-type="fig"}).

Immunohistochemistry showed keratin 14 in the basal layers ([Figure 1b](#F1){ref-type="fig"}) and involucrin in the suprabasal layers ([Figure 1c](#F1){ref-type="fig"}). Linear fluorescence at the ERU periphery of the ERU with anti-laminin antibody ([Figure 1d](#F1){ref-type="fig"}) indicated a basement membrane.

To determine whether ERUs originated from single cells, keratinocytes incubated with Vybrant™ DiI (565nm, red) or DiO (501nm, green) were mixed 1:1. One week after injection of 100,000, 40,000, 20,000 or 6,250 keratinocytes, 17/79 (21%), 5/46 (10%), 0 (0%) and 0 (0%) bi-colored ERUs, respectively ([Figure 1e, f and g](#F1){ref-type="fig"}), indicating that at lower doses ERUs originated from a single cell.

In this *in vivo* repopulation assay only EpiSCs originally injected (and their progeny) persist after 9 weeks, while transit amplifying cells (TACs) (and their progeny) are no longer present {#S4}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Long-term repopulation combined with limiting dilution analysis has been used to quantify EpiSCs ([@R49]; [@R7]; [@R55]). As short-term repopulating cells exhaust their proliferative ability over time, the frequency of ERUs decreases. When only ERUs from long-term repopulating keratinocytes remain, ERU frequency does not change at subsequent time points. Here we used a transplantation assay modified from previous studies ([@R49]; [@R55]). UNF keratinocytes were injected at a range of doses (1--100,000 cells) and the frequency of ERUs determined at different repopulation times by limiting dilution analysis ([Table1](#T1){ref-type="table"}). The frequency of ERUs decreased between 1 and 6 weeks (*P*≤0.001; n=5) from 1 in 48 (SE 1 in 35--66) to 1 in 790 (SE 1 in 576--1,084). After 6 weeks no significant change in the frequency of ERUs was detected. The overall likelihood ratio test for differences in EpiSC frequencies between weeks 1 and 24 yielded a significant result (*P*\<0.001), but between weeks 6--24 (*P* = 0.25), 9--24 (*P* = 0.63), 12--24 (*P*=0.34), and 18--24 (*P*=0.88) yielded non-significant results. In previous transplantation studies ([@R49]; [@R55]) no ERUs were lost after 9 weeks and no significant change was found after 6 weeks in the present model. Therefore, we selected 9 weeks as the time at which we are studying ERUs derived only from EpiSCs.

CD133^+^ and CD133^+^ΔΨm^hi^ keratinocytes are located in the bulge and are enriched for long-term repopulating EpiSCs {#S5}
----------------------------------------------------------------------------------------------------------------------

CD133 immunostaining was located in the bulge of neonatal and adult hair follicles, as seen in humans ([@R23]) ([Figure 2a and b](#F2){ref-type="fig"}).

For FACS isolation of CD133^+^ keratinocytes, an isotype control was used to set a gate resulting in \< 1% of total cells in the positive gate. 7AAD was used to exclude dead cells. In day 4 neonates, the CD133^+^ keratinocytes constituted 2 -- 7.6% of total (mean=4.2±3.1%, n=7) ([Figure 2c](#F2){ref-type="fig"}). In 10--12 week adults, the CD133^+^ keratinocyte population was not significantly different (2--4.2% of total cells, mean=2.8±1%, *P*=0.4, n=4).

High membrane potential (OΨm^hi^) and low membrane potential (OΨm^lo^) were defined as 5% highest and lowest TMRM fluorescence, as previously ([@R47]; [@R48]). Approximately 2% of total cells were CD133^+^ OΨm^hi^. Therefore, we selected the 2% CD133^+^ OΨm^hi^ and 2% CD133^−^ OΨm^lo^ populations. ([Figure 2d](#F2){ref-type="fig"}).

Integrin α6^hi^CD71^lo^/^hi^ keratinocytes (7--10% total) were selected based on appropriate isotype controls ([Figure 2e](#F2){ref-type="fig"}), as previously described ([@R57]; [@R31]; [@R69]).

When injected into the subcutis of NOD/SCID mice, CD133^+^ cells produced ERUs with keratinized epidermis, indistinguishable from those from UNF cells ([Figure 2f](#F2){ref-type="fig"}). 1 in 379 (SE 1 in 274--526) CD133^+^ keratinocytes was an EpiSC capable of long-term repopulation, vs. only 1 in 9,487 (SE 1 in 6,644--13,547) CD133^−^ cells. 1 in 285 (SE 1 in 220--371) CD133^+^ΔΨm^hi^ cells was capable of long-term repopulation vs. only 1 in 5,323 (SE 1 in 3,410--8,308) CD133^−^ΔΨm^lo^ cells. The enrichment provided by CD133^+^ΔΨm^hi^ vs. CD133^+^ cells was not significantly different (*P*=0.49). One in 1,488 (SE 1 in 1,079--2,052) integrin α6^hi^CD71^lo^ cells was capable of long-term repopulation, similar to UNF cells \[1 in 1,491 (SE 1 in 1,109--2,002)\] ([Figure 2g](#F2){ref-type="fig"}). Thus, the CD133^+^ population was enriched for long-term repopulating EpiSCs 3.9 fold over the UNF population and the CD133^+^ΔΨm^hi^ population was enriched for long-term repopulating EpiSCs 5.2 fold ([Figures 2g and h](#F2){ref-type="fig"}), while the CD133^−^ and CD133^−^ΔΨm^lo^ populations were depleted. The integrin α6^hi^CD71^lo^ population of keratinocytes was not enriched for long-term repopulating cells in this assay.

To exclude the possibility of contamination of CD133^+^ keratinocytes by CD133^+^ dermal papilla cells, we studied versican GFP-tagged mice that express GFP in dermal papilla cells ([@R14]; [@R26]). CD133^+^ keratinocytes isolated from versican-GFP epidermis were GFP^−^ ([Supplementary Figure S1a](#SD1){ref-type="supplementary-material"}).

In pilot studies, SSEA1^+^, CD44^+^, and CD133^+^CD44^+^ populations were not enriched in long-term repopulating EpiSCs (data not shown).

CD133^+^ and CD133^+^ΔΨm^hi^ murine keratinocytes express stem cell markers and display functional stem cell characteristics, including self-renewal, multipotency and label retention {#S6}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Overlap between CD133^+^ and previously described EpiSC markers was analyzed. Using histology, cells co-expressing CD133 and integrin α6 ([@R32]) were located in the hair follicle bulge ([Figure 3a](#F3){ref-type="fig"}). Cells co-expressing CD133 and Delta 1 (Estrach et al., 2008) were located in the bulge ([Figure 3b](#F3){ref-type="fig"}). Integrin α6^+^CD34^+^ keratinocytes exhibited EpiSC properties ([@R58];[@R59]). Using flow cytometry, 97.1±1.8% of CD133^+^ keratinocytes were integrin α6^+^ (not shown, n=4), 99±1% were CD34^+^ ([Figure 3c](#F3){ref-type="fig"}, upper panel, n=3), and 78.7±14% were integrin α6^+^CD34^+^ ([Figure 3c](#F3){ref-type="fig"}, middle panel, n=3). Only 0.8 ± 0.2% of CD133^+^ keratinocytes were integrin α6^hi^CD71^lo^ ([Figure 3c](#F3){ref-type="fig"}, lower panel, n=4). Using direct counting of FACS isolated cells, 94.3±4.2% of CD133^+^ cells ([Figure 3d](#F3){ref-type="fig"}) and 95.3±1.1% of CD34^+^ cells (not shown) were keratin 14^+^ (n=3), consistent with basal keratinocytes. Keratin 15 co-localized with label retaining cells ([@R36]; [@R37]). Using direct counting 15.5±4% of CD133^+^ keratinocytes were keratin 15^+^ ([Figure 3e](#F3){ref-type="fig"}, n=4). CD133^+^ keratinocytes were Lgr5^−^ (data not shown) ([@R22]). (4.5±2.1% of CD34^+^ cells are CD133^+^, 9.7±7.8% of integrin α6^+^ are CD133^+^ and 12.2±2.2% of integrin α6^+^CD34^+^ cells are CD133^+^). Thus, CD133^+^ keratinocytes are a subset of the α6^+^CD34^+^ bulge population.

Bmi-1 is associated with stem cell self-renewal ([@R28]; [@R44]; [@R27]). More CD133^+^, ΔΨm^hi^ and CD133^+^ΔΨm^hi^ cells expressed nuclear Bmi-1 (19.8±7.6%; *P*\<0.05, 28.7±5.3%; *P*\<0.001 and 45.9±10%; *P*\<0.001 respectively) than UNF, CD133^−^, ΔΨm^lo^ and CD133^−^ΔΨm^lo^ cells (5±2.3%, 2.8±2.6%, 6.4±4.1% and 4.8±4.5% respectively) ([Figures 4a and b](#F4){ref-type="fig"}). To further study self-renewal ability, 4,000 CD133^+^ or CD133^+^ΔΨm^hi^ and 4,000--25,000 CD133^−^ or CD133^−^ΔΨm^lo^ keratinocytes were injected into NOD/SCID mice. Primary injection sites were harvested at 9 weeks and cell suspensions obtained, followed by re-injection into secondary recipient mice. Secondary sites (harvested at 9 weeks) were analyzed microscopically. ERUs were detected in both CD133^+^ and CD133^+^ΔΨm^hi^ secondary transplants, indicating self-renewal ability, while no ERUs were detected in CD133^−^ or CD133^−^ΔΨm^lo^ secondary transplants ([Figure 4c](#F4){ref-type="fig"}, n=3). These results indicate greater self-renewal ability in the CD133^+^ and CD133^+^ΔΨm^hi^ populations.

Regeneration of hair follicles *in vivo,* using injection of mixtures of epidermal and dermal cells into immunodeficient mice is well-described ([@R72]; [@R40]; [@R66]). Multipotency was studied using co-injection of 30,000 to 90,000 keratinocytes and 100,000 neonatal (day 2) GFP-tagged dermal papilla cells. Eighteen days after injection, CD133^+^ keratinocytes formed greater numbers of hair follicles than CD133^−^ keratinocytes (22.3±2.8 vs. 2.7±2.6 hair follicles per 30,000 cells injected, respectively, *P*=0.01, n=3) ([Figure 4d](#F4){ref-type="fig"}). These follicles also expressed CD133 in the bulge ([Figure 4e](#F4){ref-type="fig"}). Injection of 100,000 dermal papilla cells did not produce hair follicles (n=4).

BrdU incorporation in neonatal mice was used to study label retaining ability as previously described ([@R4]). After a 30 day chase, 28.9±8.6% of CD133^+^ cells (n=3, 1000 cells counted) and 37.3±5.9% of CD133^+^ΔΨm^hi^ cells were label retaining cells (n=3, 1000 cells counted) ([Figure 4f](#F4){ref-type="fig"} and [Supplementary Figure S2](#SD1){ref-type="supplementary-material"}).

CD133^+^ and CD133^+^ΔΨm^hi^ murine keratinocytes have less colony forming ability *in vitro* than CD133^−^ and CD133^−^ΔΨm^lo^ keratinocytes {#S7}
---------------------------------------------------------------------------------------------------------------------------------------------

It has been assumed that colony forming efficiency (colonies/100 cells plated) reflects EpiSC number. However, greatest *in vitro* short-term proliferative ability is not associated with greatest long-term repopulating ability *in vivo* ([@R55]). 4,000 cells of each population (CD133^+^, CD133^+^ΔΨm^hi^, CD133^−^, CD133^−^ΔΨm^lo^ and UNF) were plated in 35mm dishes. The CD133^−^ and CD133^−^ΔΨm^lo^ populations showed significantly greater relative clonogenic ability (1.11±0.1 and 0.47±0.06 fold) vs. CD133^+^ and CD133^+^ΔΨm^hi^ populations (0.23±0.07 and 0.07±0.12 fold, respectively) ([Figure 5a](#F5){ref-type="fig"}). Given this *in vitro* result, we examined short-term repopulation *in vivo*. UNF and CD133^−^ populations also had greater short-term repopulating ability *in vivo* at one week vs. CD133^+^ and CD133^+^ΔΨm^hi^ populations, \[1 in 48 (SE 1 in 35--66) and 1 in 77 (SE 1 in 52--144) vs. 1 in 712 (SE 1 in 492--1032) and 1 in 495 (SE 1 in 364--671) respectively\] ([Figure 5b](#F5){ref-type="fig"}). Thus, the CD133^+^ population was enriched for keratinocytes with long-term (*in vivo*), but not short-term (*in vivo* or *in vitro*) repopulating ability. Conversely, the CD133^−^ population showed minimal long-term repopulating ability (*in vivo)*, but contained keratinocytes with short-term repopulation ability (*in vivo* and *in vitro)*.

DISCUSSION {#S8}
==========

These studies show that murine CD133^+^ keratinocytes (a subset of integrin α6^+^CD34^+^ keratinocytes) and CD133^+^ΔΨm^hi^ keratinocytes, contain long-term repopulating, self-renewing, multipotent EpiSCs containing increased proportions of cells with nuclear Bmi-1 expression and label retaining ability. The CD133^−^ population contains the clonogenic cells *in vitro* and the short-term repopulating cells *in vivo*. The CD133^+^ and CD133^+^ΔΨm^hi^ populations, while containing long-term repopulating cells, are not clonogenic *in vitro* nor short-term repopulating cells *in vivo*.

While it was believed 10% of basal cells were EpiSCs, many studies have found a frequency on a lower order ([@R49]; [@R7]; [@R1]; [@R2]; [@R60]; [@R43]; [@R65]). Here the frequency of EpiSCs was 1 in 1,491 (SE 1 in 1,109--2,002). This is expected to be an underestimate, as it is most probable that not all EpiSCs achieve proliferation in this model. In this study, keratinocytes were isolated from freshly-obtained day 2--4 neonatal murine epidermis and analyzed by FACS for integrin α6 expression. Integrin α6+ (CD49f) expressing basal cells constituted 44 ± 7 % of total keratinocytes (n= 5), in keeping with previous findings ([@R49]). Therefore, in this study, on the order of 0.01% of murine basal cells are EpiSCs. While our studies were performed using neonatal murine dorsal epidermis, our result is on the same order as that found using unperturbed adult murine epidermis *in vivo* ([@R8]).

CD133^+^ΔΨm^hi^ cells were studied for long-term repopulating ability, nuclear Bmi-1 expression, and label retention. Although nuclear Bmi-1 expression was increased in the CD133^+^ΔΨm^hi^ vs. CD133^+^ population (*p*=0.02), the EpiSC enrichment (5.2 fold vs. 3.9 fold, *P*=0.49) and the number of label retaining cells (37.3±5.9% vs. 28.9±8.6%, *P*=0.23) in CD133^+^ΔΨm^hi^ keratinocytes was not significantly different. Also, while there is strong evidence for integrin α6^hi^CD71^lo^ as a marker of human EpiSCs ([@R25]; [@R32]; [@R31]; [@R33]) and *in vitro* studies showed that integrin α6^hi^CD71^lo^ murine keratinocytes are quiescent and small, with high nuclear/cytoplasmic ratio ([@R57]; [@R67]), our studies indicated that murine integrin α6^hi^CD71^lo^ keratinocytes are not enriched for long-term repopulating cells *in vivo*, in this assay. Other functional characteristics of integrin α6^hi^CD71^lo^ cells were not tested.

CD133^+^ cells were bulge cells and were CD34^+^ \[AC133 antibody was produced by inoculation of CD34^+^ human cells ([@R68]; [@R3])\]. While 94.3±4.2% of CD133^+^ keratinocytes were keratin 14^+^, there may exist a more primitive K14^−^ stem cell. While side population cells were integrin α6^hi^CD71^lo^ ([@R43]), CD34^−^ and distinct from the bulge population ([@R43]), 99±1% of CD133^+^ keratinocytes were distinct from integrin α6^hi^CD71^lo^ cells, CD34^+^ and localized in the hair follicle bulge. CD133^+^ cells thus appear to be distinct from both integrin α6^hi^CD71^lo^ cells and side population cells.

CD133^+^ cells are keratinocytes because CD133^+^ (CD34^+^) cells are keratin 14^+^ and integrin α6^+^, consistent with basal epidermal cells. Possible contamination of CD133^+^ keratinocytes by CD133^+^ dermal papilla cells was excluded using versican GFP-tagged mice (CD133^+^ dermal papilla cells are GFP^+^). Isolated CD133^+^ keratinocytes were GFP^−^. Furthermore, the GFP^+^/CD133^+^ dermal papilla cells were less than 2% of pure dermal papilla cell preparations, so that contaminating CD133^+^ cells could not explain the 4.2±3.1% CD133^+^ cells consistently found in the total keratinocyte preparation. Finally, isolated CD133^+^ cells grow a stratified epithelium in vivo, not dermal tissue, when injected into murine subcutis.

The colony forming efficiency results reflected short-term *in vivo* results. CD133^−^ keratinocytes were clonogenic *in vitro* and were short-term repopulating cells *in vivo*. CD133^+^ cells didn't grow *in vitro* and were not short-term repopulating cells *in vivo*, but were long-term repopulating cells *in vivo*. Culture conditions may favor proliferation of TACs and/or reprogram proliferative ability \[for review see ([@R12])\] or *in vitro* analysis may reflect a wounding response, not homeostasis ([@R24]). These results are consistent with the belief that stem cells have minimal clonogenic ability *in vitro* and that not all colony forming cells constitute stem cells ([@R42]; [@R5]; [@R32]; [@R52]; [@R55]; [@R51]; [@R35]; [@R34]).

Lineage tracing indicates that follicular cells do not contribute to interfollicular epidermis during homeostasis (Gazizadeh et al, 2001; [@R40]; [@R61]; [@R29]; [@R20]). Keratin 15^+^ bulge cells formed interfollicular epidermis in transplantation assays (at 4 weeks) ([@R40]), but lineage analysis after wounding demonstrated that keratin 15^+^ bulge cells and their progeny contribute to the interfollicular epidermis only transiently, while unlabeled cells persisted ([@R20]). In another study, lineage tracing after wounding demonstrated that Shh-expressing cells (present throughout the pilosebaceous unit and comprising both keratin 15^+^ and keratin 15^−^ cells) and their progeny contributed to interfollicular epidermis for at least 4 months ([@R30]). By contrasting and synthesizing the results of these two sets of experiments Levy et al suggested the possibility of a distinct cell in the follicle (derived from Shh^+^ but not keratin 15^+^ cells) with the ability to become a long-term repopulating stem cell of interfollicular epidermis ([@R30]). Our studies show that bulge-derived CD133^+^ cells (85% keratin 15^−^) form both interfollicular epidermis and hair follicles in transplantation assays and form interfollicular epidermis for the long-term (9 weeks). Future lineage tracing is indicated to determine how CD133^+^ cells and their progeny contribute to follicular and interfollicular epidermis *in vivo,* during homeostasis as well as wounding.

Finally, our results characterize CD133^+^ EpiSCs using functional properties and provide a basis for future studies aimed at quantitative comparison of the enrichment in long-term repopulating stem cells and short-term repopulating progenitors provided by different EpiSC isolation strategies.

MATERIALS AND METHODS {#S9}
=====================

Mice {#S10}
----

IACUC approval (VAMC San Francisco, CA) was obtained and work performed in adherence to institutional guidelines. C57BL/6TgN(ACTbEGFP1Osb), NOD/SCID (Jackson Laboratory, <http://www.jax.org>) and Versican GFP-tagged transgenic mice (kindly provided by Jiro Kishimoto as a gift to Daniel Bikle) ([@R14]; [@R26]) were used.

Keratinocyte and Fibroblast isolation {#S11}
-------------------------------------

Excised skin was incubated in dispase and then trypsin ([@R49]) and a cell suspension obtained. Fibroblasts were isolated by incubating the dermis in 0.25% collagenase IA (Sigma-Aldrich, St. Louis, <http://www.sigmaaldrich.com>) at 37°C for 1h.

Flow Cytometry {#S12}
--------------

Keratinocytes were sorted using a FACSAria (BD Biosciences) and analyzed with CellQuest™ software. Antibodies included APC-CD133 \[AC133 ([@R10]; [@R46]; [@R54])\], APC-IgG1K isotype control, Alexa Fluor® 488-SSEA-1, PE-CD44 (all from eBioscience, San Diego, CA, <http://www.ebioscience.com>) and FITC-integrin α6, FITC-IgG2a isotype control, PE-CD71, [PE-IgG1K isotype control]{.ul} and FITC-CD34 (all from BD Pharmingen, San Diego, CA). PE-integrin α6 antibody was from Abcam (Cambridge, MA, <http://www.abcam.com>).

To sort for keratinocytes with high ΔΨm, cells were treated with TMRM 25nM for 15min ([@R47]; [@R48]). Cells with high ΔΨm accumulate more of this potentiometric dye. (Invitrogen).

Epidermal regeneration *in vivo* {#S13}
--------------------------------

Keratinocytes in Progenitor Cell Technology Epidermal Keratinocyte Medium Complete (CNT07, Chemicon, Temecula, CA, <http://www.chemicon.com>) were injected with Matrigel™ (0.5 mg/ml; BD Biosciences) 1:1 (vol:vol) into the subcutis of NOD/SCID mice. CNT-07 is a protein-free fully-defined, calcium 0.07 mM formulation with no antibiotics/antimycotics, containing amino acids, minerals, vitamins and organic compounds. Grafts were harvested and examined for the presence of ERUs histologically.

Limiting Dilution Analysis of ERU Frequency {#S14}
-------------------------------------------

For each time point injection sites were scored as positive if at least one ERU was observed microscopically ([@R49]) and the ratio of positive/total sites determined for each dose. Statistical software for limiting dilution analysis (L-CALC, Stemsoft, Vancouver, BC, Canada, <http://www.stemsoft.com>) was used. The Chi square statistic was used and 5% or less type I error considered significant.

Immunohistochemistry {#S15}
--------------------

Involucrin and keratin 14 primary antibodies (Abcam) and VECTASTAIN Elite ABC reagent followed by ImmPACT NovaRED Peroxidase Substrate (Vector, Burlingame, CA) were used on paraffin-embedded sections.

Immunofluorescence {#S16}
------------------

Antibodies included CD133 (AC133) (eBioscience), laminin, Delta1, Lgr5, Keratin15, Keratin14 and Bmi-1 (all from Abcam) and integrin α6 (Santa Cruz Biotechnology, Inc, Santa Cruz, CA, <http://www.scbt.com/>). AlexaFluor 488-IgF1 (H+L), AlexaFluor 594-IgG and AlexaFluor 488-IgG (Invitrogen) secondaries were used on cell cytospins and paraffin-embedded sections. 300--500 cells were analyzed per sample.

Label retaining cells {#S17}
---------------------

Three-day mice were injected twice daily for 3 days with BrdU (75 µg/dose). Skin was collected 30 days later. FITC conjugated BrdU antibody (Abcam) was used to localize label retaining cells using microscopy.

Multipotency {#S18}
------------

CD133^+^ or CD133^−^ keratinocytes and Versican GFP-tagged dermal papilla cells (day 2) mixed with Matrigel™ 1:1 (vol:vol) were injected into NOD/SCID subcutis. Grafts were harvested 18 days after injection and examined histologically.

Colony Forming Efficiency {#S19}
-------------------------

Keratinocytes were seeded at clonal density (100--500 cells per cm^2^) ([@R55]; [@R39]) onto six-well plates with CNT07 medium. After 3--4 weeks cells were fixed, stained with toluidine blue (Sigma-Aldrich), and colony forming efficiency (number of colonies per 100 cells seeded) was expressed relative to UNF.

Statistical analysis {#S20}
--------------------

For comparisons of colony forming efficiency, percentage of cells exhibiting nuclear Bmi-1 and percentage of ERUs labeled with both DiI and DiO, a two-tailed Student's t test was used. For comparisons of the frequency of repopulating units in each subpopulation at each time point, a two-tailed t test within the L-CALC program (Stemsoft Software Inc) was used.
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![Generation of ERUs following subcutaneous injection of murine keratinocytes in an allograft model\
**(a)** ERUs formed following injection of GFP^+^ murine keratinocytes into a GFP^−^ NOD/SCID mouse are GFP^+^ confirming derivation from the GFP^+^ donor keratinocytes. Fluorescence microscopy (488 nm) (left panel). H&E of an adjacent section (right panel). 100 ERUs were analyzed (3 experiments). **(b--d)** Epidermal differentiation is seen in ERUs. **(b)** Keratin 14 is expressed in the basal layers. **(c)** Involucrin is expressed in the suprabasal epidermis. **(d)** Laminin is present at the basement membrane of the ERU. Positive controls were intact murine epidermis. Negative controls were performed with omission of the primary antibody. **(e--g)** ERUs are formed from single cells. Keratinocytes were labeled with Vybrant™DiI or DiO and mixed in a 1:1 ratio before injection into NOD/SCID mice. Resultant ERUs (arrow heads) were green or red, but not mixed. **(e)** Four of the ERUs produced by injection of 20,000 keratinocytes. Fluorescence microscopy (left panel), DCI of the same section (middle panel) and H&E of the adjacent section (right panel). **(f)** A DiO positive ERU and **(g)** a DiI positive ERU. Scale bars = 10 µm in **a--d**; 25 µm in **e**; and 10 µm in **f** and **g**.](nihms375258f1){#F1}

![CD133^+^ and CD133^+^ΔΨm^hi^ keratinocytes are located in the murine bulge and are enriched for long-term repopulating epidermal stem cells\
[**(a, b)** CD133 expression in the hair follicle bulge of neonatal and adult murine epidermis. In addition, CD133 was expressed in the derma papilla cells (asterisk\*) ([@R21]). Immunofluorescence using confocal microscopy]{.ul}. **(c)** Isolation of CD133^+^ and **(d)** isolation of CD133^+^ΔΨm^hi^ murine keratinocytes based on isotype control. **(e)** Isolation of integrin α6^hi^CD71^lo^ murine keratinocytes. The selected population was based on the 7--10% of cells most α6 integrin^hi^CD71^lo^ (putative EpiSCs). A second population (right upper quadrant) was also selected based on the 7--10% of cells most α6 integrin^hi^CD71^hi^ (putative TACs) ([@R25]; [@R31]; [@R32]; [@R33]) (based on isotype controls). **(f)** ERUs formed following injection of CD133^+^ keratinocytes into a NOD/SCID mouse. **(g)** EpiSC frequency, based on in vivo transplantation combined with limiting dilution analysis, in isolated keratinocyte populations at 9 weeks. **(h)** Summary of the data in Figure 2g. Bar graph showing the fold enrichment over UNF keratinocytes for the selected populations. Error bars = mean±SE (\* *P*≤0.05; \*\**P*≤0.001; n=3). Scale bars= 10 µm for **a, b, f.** bg= bulge](nihms375258f2){#F2}

![CD133^+^ keratinocytes co-localize with integrin α6^+^, Delta1^+^ and CD34^+^ keratinocytes\
**(a)** CD133 and α6 integrin co-expressing keratinocytes in the bulge (arrows). **(b)** CD133 and Delta-1 co-expressing keratinocytes in the bulge (arrows). **(c)** Overlap between CD133^+^, CD34^+^ and integrin α6 populations. CD133^+^ cells are CD34^+^ (upper panel), integrin α6^+^CD34^+^ (middle panel) and not integrin α6^hi^CD71^lo^ (lower panel). **(d)** 94.3±4.2% of CD133^+^ keratinocytes were keratin 14^+^ (direct counting, 200--500 cells/experiment). **(e)** 15.5±4% of CD133^+^ cells were keratin 15^+^ (direct counting, 200--500 cells/experiment). Scale bars= 10 µm. bg= bulge](nihms375258f3){#F3}

![CD133^+^ and CD133^+^ΔΨm^hi^ murine keratinocytes display stem cell characteristics\
**(a)** Nuclear expression of Bmi-1 in CD133^+^, ΔΨm^hi^ and CD133^+^ΔΨm^hi^ keratinocytes. Cells with nuclear expression (Nuc), cytoplasmic expression (C) or no expression (x) were counted (ε100 cells per population). **(b)** Bar graph of the percentage of cells with nuclear Bmi-1 expression. Error bars = mean±SD (\* *P*≤0.05; \*\**P*≤0.001; n=3). **(c)** ERUs were produced after secondary transplantation of ERUs from 4,000 CD133^+^ and 4,000 CD133^+^ΔΨm^hi^ keratinocytes but not after secondary transplantation of ERUs from 4,000 CD133^−^ and 4,000 CD133^−^ΔΨm^lo^ keratinocytes. **(d)** Hair follicles derived from CD133^+^ keratinocytes that were co-injected with day 2 murine dermal papilla cells (H&E). Bar graph: error bars = mean±SD, *P*=0.001, n=3). **(e)** CD133 immunostaining of hair follicle derived from CD133^+^ keratinocytes co-injected with day 2 murine dermal papilla cells and H&E of the adjacent section. **(f)** 28.9±8.6% of CD133^+^ and 37.3±5.9% of CD133^+^ΔΨm^hi^ keratinocytes are label retaining cells (arrows indicate BrdU^−^ cells; mean ± SD, n=3). Scale bars= 10 µm for **a, c, f;** 50 µm for **d** (low power images); 10 µm for **d** (high power images); 20 µm for **e**. bg=bulge; hf=hair follicle](nihms375258f4){#F4}

![In both *in vitro* and *in vivo* studies the short-term repopulating cells reside in the CD133^−^ population, rather than the CD133^+^\
**(a)** Murine keratinocyte populations were sorted and 4,000 cells plated in each well. After 3--4 weeks wells were stained with toluidine blue. Relative colony forming efficiency of CD133^+^, CD133^+^ΔΨm^hi^, CD133^−^ and CD133^−^ΔΨm^lo^ keratinocytes is shown in the bar graph. Error bars = mean±SD (\**P*≤ 0.05; n=3) **(b)** Assessment of ERU frequency using *in vivo* transplantation and limiting dilution analysis at 1 week (short-term repopulation) *in vivo*.](nihms375258f5){#F5}

###### 

Frequency of epidermal repopulating units at different durations of repopulation

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Duration of\                                                         \                                                \                                                             \                 \                 \                 \                 
  repopulation                                                         1 week                                           6 weeks                                                       9 weeks           12 weeks          18 weeks          24 weeks          
  -------------------------------------------------------------------- ------------------------------------------------ ------------------------------------------------------------- ----------------- ----------------- ----------------- ----------------- ------
                                                                                                                        Response ratio: positive samples/total number of injections                                                                           

  100,000                                                                                                               1/1                                                           5/5               3/4               5/5               4/4               5/6

  25,000                                                                                                                4/4                                                           4/4               3/3               7/7               3/3               4/4

  6,250                                                                                                                 4/4                                                           9/9               6/7               9/10              2/2               3/3

  1,562                                                                                                                 4/4                                                           8/11              10/13             7/11              3/7               4/11

  391                                                                                                                   4/4                                                           3/6               3/7               3/7               3/5               6/12

  98                                                                                                                    7/9                                                           2/4               0/4               0/5               1/3               2/7

  24                                                                                                                    6/11                                                          1/4               0/1               0/1                                 2/3

  5                                                                                                                     0/1                                                                                                                                   

  1                                                                                                                     0/2                                                                                                                                   

  **ERU Frequency**\                                                   1 in **48**[\*\*](#TFN1){ref-type="table-fn"}\   1 in **790**\                                                 1 in **1,491**\   1 in **1,802**\   1 in **1,373**\   1 in **1,242**\   
  \                                                                    \                                                \                                                             \                 \                 \                 \                 
  SE[1](#TFN2){ref-type="table-fn"}, [2](#TFN3){ref-type="table-fn"}   35--66                                           576--1,084                                                    1,109--2,002      1,342--2,420      917--2,054        921--1,674        
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*p* ≤ 0.001 between 1 week and all the other time points

SE expressed as 1 in...

Tests for inconsistency (CHI-Square Pearson, Deviance) were NS
